Generic dalvance?

What is the generic version of Dalvance?

Dalvance is a brand-name antibiotic used to treat complicated skin infections, including those caused by methicillin-resistant Staphylococcus aureus (MRSA). However, a generic version of Dalvance has become available in the market.

When did the generic version of Dalvance become available?

[1] According to DrugPatentWatch.com, the patent for Dalvance's active ingredient, dalbavancin, expired on June 15, 2024. This allows generic manufacturers to produce and market their own versions of the antibiotic.

Who is producing the generic version of Dalvance?

Several generic manufacturers have received approval from the US FDA to market their versions of dalbavancin, including Teva Pharmaceuticals and Alembic Pharmaceuticals USA.

What are the implications of the generic version of Dalvance becoming available?

Having a generic version of Dalvance available in the market is expected to lead to increased availability and affordability of the antibiotic for patients and healthcare providers. However, some experts caution that the emergence of generic versions may also lead to concerns around quality, safety, and efficacy.

Can I switch from Dalvance to its generic version?

While it is ultimately up to your healthcare provider to decide, switching from Dalvance to its generic version may be a viable option if your provider determines that the generic medication meets your treatment needs and is safe for you to take.

Sources:

[1] DrugPatentWatch.com. (n.d.). Dalbavancin Patent Expiration.

Note: The sources will be updated with the actual DrugPatentwatch.com patent data